Bank Of America Corp Oramed Pharmaceuticals Inc. Transaction History
Bank Of America Corp
- $1.12 Trillion
- Q2 2024
A detailed history of Bank Of America Corp transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Bank Of America Corp holds 173,241 shares of ORMP stock, worth $401,919. This represents 0.0% of its overall portfolio holdings.
Number of Shares
173,241
Previous 287,052
39.65%
Holding current value
$401,919
Previous $838,000
46.9%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ORMP
# of Institutions
61Shares Held
6.36MCall Options Held
0Put Options Held
0-
Murchinson Ltd. Toronto, A61.7MShares$3.94 Million0.77% of portfolio
-
Bml Capital Management, LLC Zionsville, IN1.35MShares$3.13 Million2.47% of portfolio
-
Boothbay Fund Management, LLC New York, NY825KShares$1.91 Million0.06% of portfolio
-
Morgan Jess S & CO Inc366KShares$850,0502.07% of portfolio
-
Rathbones Group PLC Liverpool, X0290KShares$672,3420.0% of portfolio
About ORAMED PHARMACEUTICALS INC.
- Ticker ORMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,100
- Market Cap $90.1M
- Description
- Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...